Search for: "WYETH PHARMACEUTICALS COMPANY"
Results 441 - 460
of 547
Sort by Relevance
|
Sort by Date
15 Oct 2008, 3:02 pm
The Supreme Court wil shortly hear these arguments in the context of a drug case and FDA preamble that attempts to grant immunity, when Wyeth v. [read post]
13 Oct 2008, 2:25 am
A Vermont woman was awarded more than $6 million when a jury ordered Wyeth, a pharmaceutical company, to pay her for failing to warn her about the risks of one of its drugs. [read post]
10 Oct 2008, 11:32 am
You can separately subscribe to the Pharma & Biotech edition of the IP Thinktank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Mircera (Methoxy polyethylene glycol-epoetin beta) - US: Trial judge grants permanent injunction in case relating to recombinant erythropoietin (EPO) patent: Amgen v… [read post]
7 Oct 2008, 4:54 am
Friend of the court briefs urging the Court to adopt Wyeth's position have been filed by pharmaceutical groups, the U.S. [read post]
2 Oct 2008, 12:36 pm
Astrazeneca Pharmaceuticals, LP, 500 F.Supp.2d 736 (S.D. [read post]
1 Oct 2008, 1:57 am
This legal strategy by the pharmaceutical companies will be reviewed by the United States Supreme Court in the case of Wyeth v. [read post]
30 Sep 2008, 6:20 pm
Wyeth case before the United States Supreme Court could effectively end the chance to litigate against a pharmaceutical drug company if that company produces a harmful drug when it had previous knowledge that the drug was dangerous. [read post]
19 Sep 2008, 7:13 am
Levine may keep more than $6 million that a Vermont jury ordered Wyeth, a pharmaceutical company, to pay her for failing to warn her adequately about the risks of one of its drugs. [read post]
16 Sep 2008, 8:15 pm
Levine is expected to have widely felt consequences for those seeking to recover damages from pharmaceutical companies. [read post]
15 Sep 2008, 1:53 pm
The case, called Wyeth v. [read post]
25 Aug 2008, 10:55 am
Wyeth, Inc., 2006 WL 462470 (N.J. [read post]
24 Aug 2008, 10:16 am
.; Dow Corning Ltd; Dyson Technology Ltd; ExxonMobil Chemical Ltd; Ford of Europe; Fujitsu Services Ltd; G E Healthcare; GKN plc; GlaxoSmithKline plc; Hewlett-Packard Ltd; IBM UK Ltd; Infineum UK Ltd; Kodak Ltd; Merck Sharp & Dohme Ltd; Microsoft Ltd; Nestle UK Ltd; Nokia UK Ltd; NXP Semiconductors UK Limited; Pfizer Ltd; Philips Electronics UK Ltd; Pilkington Group Ltd; Procter & Gamble Ltd; QinetiQ Ltd; Renishaw plc; Rohm and Haas (UK) Ltd; Rolls-Royce plc; Shell International Ltd;… [read post]
23 Aug 2008, 1:23 am
: (Part 1 - SPICY IP), (Part 2 - SPICY IP) Global – Copyright International Federation of the Phonographic Industry (IFPI): ‘Three strikes’ effort hit worldwide home run: (Ars Technica), How to attribute a Creative Commons licensed work: (Molly Kleinman), Chrysalis disappoints, as new artists fail to incubate: (IP finance), DRM for streaming music dies a quiet death: (Electronic Frontier Foundation), (Techdirt) Events 26 August:… [read post]
20 Aug 2008, 9:54 pm
Levine this November which could have far reaching implications as to pharmaceutical cases against drug companies, including those in Illinois and the Chicago area. [read post]
18 Aug 2008, 3:53 pm
One of the most closely watched cases of the Supreme Court's upcoming term is Wyeth v. [read post]
15 Aug 2008, 7:39 pm
The New England Journal of Medicine has filed a friend of the court brief to the United States Supreme Court in the case of Wyeth v. [read post]
8 Aug 2008, 5:00 pm
We haven't yet said a peep about the FAS 5 brouhaha.And, Lord knows, we haven't had to.In a nutshell, the Financial Accounting Standards Board has proposed to amend FASB Statement No. 5 to require companies to make additional disclosures about pending "loss contingencies," which means making more public statements about pending litigation.For some of the massive reaction to FASB's proposal, see The Wall Street Journal's editorial on August 7 or the D and O… [read post]
28 Jul 2008, 4:26 pm
Officials from Wyeth and a paid advisor to big pharmaceutical clients. [read post]
28 Jul 2008, 10:41 am
When a new safety issue emerges with a product, the pharmaceutical company may temporarily add to the product's labeling under this rule, which describes "changes that may be made before FDA approval. [read post]
21 Jul 2008, 3:31 am
Sanofi already owns 25% of the company. [read post]
